Antigen-driven regulation of experimental autoimmune encephalomyelitis

This publication has 92 references indexed in Scilit:

• Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system
  European Journal of Immunology, 1997
• Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the Disease
  The Journal of Experimental Medicine, 1997
• Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of lewis rats with myelin basic protein
  Experimental Neurology, 1995
• Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains
  Published by Elsevier ,1994
• Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.
  Journal of Clinical Investigation, 1994
• Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10
  Journal of Neuroimmunology, 1993
• Disruption of the murine IL-4 gene blocks Th2 cytokine responses
  Nature, 1993
• Monoclonal Anti-Gamma Interferon Antibodies Enhance Experimental Allergic Encephalomyelitis
  Autoimmunity, 1993
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
  Nature, 1992
• Generation and Analysis of Interleukin-4 Deficient Mice
  Science, 1991